Why the study?
Does atenolol reduce arterial pressure in patients with benign essential hypertension?
Does atenolol reduce arterial pressure in patients with benign essential hypertension?
Atenolol significantly reduces both supine and erect arterial pressure in patients with benign essential hypertension compared to placebo.
Answers are grounded in this paper and cite their sources.
Atenolol effectively lowers BP in essential hypertension; supports beta-blocker use in this RCT population.
The effect of atenolol, a beta adrenoceptor autogonist, on arterial pressure in patients with benign essential hypertension has been investigated. Eighteen patients were started on atenolol, 75 mg/day; the dose was increased at 2-wk intervals to a maximum of 900 mg if tolerated. When the maximum effective dose was determined, each patient was randomly allocated into a double-blind crossover study comparing atenolol and placebo treatments. The mean supine and erect arterial pressures of the 16 patients completing the run-in period were markedly reduced by atenolol therapy. The pretreatment mean (+/-SEM) supine and erect arterial pressures of the 16 patients completing the run-in period (187 +/-4.7/114 +/-2.6 and 182 +/-4.5/115 +/-3.0 mm Hg, respectively) were reduced (150 +/-5.3/97 +/-2.9 and 151 +/-5.9/100 +/-2.7 mm Hg) with atenolol therapy (p less than 0.01). In the crossover study, the mean (+/-SEM) supine arterial pressure after 8 wk of atenolol therapy in 14 patients (144 +/-5.2/89 +/-1.7 mm Hg) was lower (p less than 0.01) than at the end of placebo therapy (163 +/-4.4/105 +/-2.8 mm Hg). Similar reductions in pressure were recorded in the erect position and after exercise. No severe side effects were observed.
No takes yet. Share an insight, caveat, or question.
Myers et al. (1976) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: